非选择性（普萘洛尔）和心脏选择性（美托洛尔）β-肾上腺素能受体阻滞剂在静息和运动时的降压作用。
Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.
作者信息
Clausen N, Damsgaard T, Mellemgaard K
出版信息
Br J Clin Pharmacol. 1979 Apr;7(4):379-83. doi: 10.1111/j.1365-2125.1979.tb00949.x.
Abstract
1 The antihypertensive effects at rest and during physical exercise of the non-selective beta-adrenoceptor blocker propranolol and the cardioselective beta-adrenoceptor blocker metoprolol were compared in a double-blind cross-over study. 2 Eighteen patients with mild hypertension entered the trial. One patient was withdrawn from the study due to side effects on both drugs. 3 The two beta-adrenoceptor blockers were compared using doses earlier shown to have the same beta-adrenoceptor blocking potency, as measured by their effect on exercise tachycardia in healthy men. 4 Arterial blood pressure was reduced to the same extent by propranolol and metoprolol at rest as well as during submaximal work. 5 It is concluded that the antihypertensive effect of beta-adrenoceptor blockers is mainly mediated through blockade of the beta 1-adrenoceptors.
摘要
- 在一项双盲交叉研究中，比较了非选择性β肾上腺素能受体阻滞剂普萘洛尔和心脏选择性β肾上腺素能受体阻滞剂美托洛尔在静息和体育锻炼期间的降压效果。2. 18例轻度高血压患者进入试验。1例患者因对两种药物均有副作用而退出研究。3. 使用先前显示具有相同β肾上腺素能受体阻断效力的剂量比较这两种β肾上腺素能受体阻滞剂，该效力通过它们对健康男性运动性心动过速的影响来衡量。4. 普萘洛尔和美托洛尔在静息时以及次最大运动量期间均将动脉血压降低到相同程度。5. 得出结论，β肾上腺素能受体阻滞剂的降压作用主要通过阻断β1肾上腺素能受体介导。
相似文献
1
Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.非选择性（普萘洛尔）和心脏选择性（美托洛尔）β-肾上腺素能受体阻滞剂在静息和运动时的降压作用。
Br J Clin Pharmacol. 1979 Apr;7(4):379-83. doi: 10.1111/j.1365-2125.1979.tb00949.x.
2
Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.普萘洛尔和美托洛尔对高血压患者运动期间血流动力学和呼吸指标以及自觉用力程度的影响。
Br Heart J. 1979 Jan;41(1):99-105. doi: 10.1136/hrt.41.1.99.
3
Effect of beta-adrenoceptor blockade on exercise performance and metabolism.β-肾上腺素能受体阻断对运动能力和代谢的影响。
Clin Sci (Lond). 1981 Sep;61(3):299-305. doi: 10.1042/cs0610299.
4
The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.一种心脏选择性（美托洛尔）和一种非选择性（普萘洛尔）β-肾上腺素能阻滞剂对正常男性动态运动反应的影响。
Circulation. 1982 May;65(5):894-9. doi: 10.1161/01.cir.65.5.894.
5
Cardioselective (metoprolol) and non-selective (propranolol) beta-blockade and glucose homeostasis.心脏选择性（美托洛尔）和非选择性（普萘洛尔）β受体阻滞剂与葡萄糖稳态
Ann Clin Res. 1977 Oct;9(5):292-5.
6
Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.对美托洛尔（一种心脏选择性β受体阻滞剂）在心绞痛患者慢性治疗期间的评估。
J Int Med Res. 1976;4(1):15-22. doi: 10.1177/030006057600400102.
7
Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.β-肾上腺素能受体阻滞剂与糖尿病患者的血糖控制
Br Med J. 1979 Jan 20;1(6157):159-61. doi: 10.1136/bmj.1.6157.159.
8
The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.普萘洛尔、心得宁和美托洛尔对人体运动诱发心动过速的影响及其与血浆水平的关系。
Clin Exp Pharmacol Physiol. 1976 Sep-Oct;3(5):473-82. doi: 10.1111/j.1440-1681.1976.tb00625.x.
9
beta-Adrenoceptor blockers, plasma-potassium, and exercise.β-肾上腺素能受体阻滞剂、血钾与运动
Lancet. 1978 Aug 19;2(8086):424-5. doi: 10.1016/s0140-6736(78)91893-7.
10
Lower limb haemodynamics during antihypertensive treatment with metoprolol and propranolol.
Int Angiol. 1985 Apr-Jun;4(2):225-8.
引用本文的文献
1
Blood pressure and catecholamines following exercise during selective beta-blockade in hypertension.高血压患者在选择性β受体阻滞剂治疗期间运动后的血压和儿茶酚胺水平
Eur J Clin Pharmacol. 1986;30(3):283-7. doi: 10.1007/BF00541529.
本文引用的文献
1
Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.高血压中的β肾上腺素能阻滞剂。长期血流动力学变化的实际和理论意义。
Am J Cardiol. 1972 May;29(5):633-40. doi: 10.1016/0002-9149(72)90164-6.
2
Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.新型β-肾上腺素能阻滞剂ICI66.082的降压作用
Int J Clin Pharmacol. 1974 Oct;10(3):206-11.
3
Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.新型β-肾上腺素能阻滞剂ICI 66.082治疗高血压的初步临床经验。
Acta Med Scand. 1973 Dec;194(6):549-50. doi: 10.1111/j.0954-6820.1973.tb19489.x.
4
Metoprolol in the long-term treatment of hypertension.
Practitioner. 1976 Dec;217(1302):953-7.
5
A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.阿替洛尔（ICI 66 082）与普萘洛尔降压效果的比较。
Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):361-5. doi: 10.1007/BF00606549.
6
Controlled study of atenolol in treatment of hypertension.阿替洛尔治疗高血压的对照研究。
Br Med J. 1975 May 17;2(5967):367-70. doi: 10.1136/bmj.2.5967.367.
7
Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study.
Acta Med Scand. 1976;199(1-2):71-4. doi: 10.1111/j.0954-6820.1976.tb06693.x.
Zotero 插件